O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.71B
AUM Growth
-$772M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
149
New
Increased
Reduced
Closed

Top Buys

1
+$130M
2
+$104M
3
+$99.3M
4
BOLD
Audentes Therapeutics, Inc
BOLD
+$85.5M
5
EXEL icon
Exelixis
EXEL
+$79.4M

Top Sells

1
+$211M
2
+$155M
3
+$148M
4
BSX icon
Boston Scientific
BSX
+$141M
5
RLYP
RELYPSA INC COM
RLYP
+$137M

Sector Composition

1 Healthcare 93.45%
2 Financials 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$418M 4.76%
1,333,900
-166,500
2
$410M 4.67%
17,211,700
-5,917,500
3
$406M 4.63%
2,436,700
-596,800
4
$323M 3.68%
2,638,011
-343,400
5
$308M 3.51%
2,948,577
+543,900
6
$267M 3.04%
4,229,900
-2,343,200
7
$219M 2.49%
3,675,126
+1,667,682
8
$206M 2.35%
1,063,351
+669,342
9
$184M 2.1%
1,120,000
10
$180M 2.06%
7,356,233
+811,070
11
$179M 2.04%
778,690
-565,925
12
$175M 1.99%
3,714,800
+149,600
13
$174M 1.99%
1,850,178
-474,500
14
$166M 1.89%
4,119,600
+2,585,400
15
$164M 1.87%
2,040,500
+563,700
16
$160M 1.82%
2,383,525
-580,500
17
$159M 1.81%
2,010,700
-1,062,200
18
$158M 1.8%
11,879,106
19
$154M 1.75%
2,634,700
+796,700
20
$146M 1.66%
1,248,000
-670,500
21
$143M 1.63%
355,300
-154,600
22
$141M 1.6%
1,612,000
-577,300
23
$136M 1.55%
1,690,200
-990,000
24
$130M 1.48%
816,500
-560,700
25
$120M 1.36%
3,722,939
-749,921
1
2 3 4 5